## iRECIST vs RECIST 1.1: Unchanged
* Definitions of measurable, non-measurable disease 
* Definitions of target (T) and non target (NT) lesions 
* Measurement and management of nodal disease 
* Calculation of the sum of measurement (SOM) 
* Definitions of complete (CR) and partial response (PR), stable disease (SD) and their duration 
* Confirmation of CR and PR and when applicable 
* Definition of progression in T and NT (iRECIST terms i-unconfirmed progression (iUPD))
